Chlamydial vulvovaginitis
ICD-10 A56.02 is a billable code used to indicate a diagnosis of chlamydial vulvovaginitis.
Chlamydial vulvovaginitis is an infection of the vulva and vagina caused by the bacterium Chlamydia trachomatis, a common sexually transmitted infection (STI). This condition often presents with symptoms such as vaginal discharge, itching, burning sensations, and discomfort during intercourse. In many cases, chlamydial infections can be asymptomatic, particularly in women, which can lead to delayed diagnosis and treatment. The infection can also ascend to the upper reproductive tract, potentially causing pelvic inflammatory disease (PID) if left untreated. Diagnosis is typically confirmed through nucleic acid amplification tests (NAATs) or other laboratory methods. Treatment usually involves a course of antibiotics, such as azithromycin or doxycycline, and it is crucial to treat sexual partners to prevent reinfection. Regular screening for STIs is recommended for sexually active individuals, particularly those under 25 years of age or with multiple partners, to facilitate early detection and management.
Detailed patient history, including sexual history, symptoms, and treatment plans.
Patients presenting with vaginal discharge, pelvic pain, or abnormal bleeding.
Ensure documentation reflects the need for partner treatment and follow-up care.
Comprehensive lab results, treatment regimens, and follow-up plans.
Patients with recurrent STIs or those with complex medical histories.
Focus on co-infections and comprehensive treatment strategies.
Used when testing for chlamydia in symptomatic patients.
Document the reason for testing and any symptoms present.
Ensure proper coding for the test based on the patient's clinical presentation.
Common symptoms include vaginal discharge, itching, burning sensations, and discomfort during intercourse. However, many individuals may be asymptomatic.
